| Primary |
| Mechanical Ventilation |
31.3% |
| Induction Of Anaesthesia |
12.5% |
| Anaesthesia |
6.3% |
| Anaesthesia Procedure |
6.3% |
| Completed Suicide |
6.3% |
| Neuromuscular Blocking Therapy |
6.3% |
| Status Asthmaticus |
6.3% |
| Analgesic Effect |
3.1% |
| Antibiotic Prophylaxis |
3.1% |
| Asthma |
3.1% |
| Cardiac Failure |
3.1% |
| Hypotonia |
3.1% |
| Muscle Relaxant Therapy |
3.1% |
| Respiratory Disorder |
3.1% |
| Sedative Therapy |
3.1% |
|
| Deafness Neurosensory |
31.0% |
| Quadriplegia |
10.3% |
| Death |
6.9% |
| Muscular Weakness |
6.9% |
| Overdose |
6.9% |
| Anaphylactic Reaction |
3.4% |
| Anaphylactic Shock |
3.4% |
| Anaphylactoid Reaction |
3.4% |
| Angioedema |
3.4% |
| Completed Suicide |
3.4% |
| Gastrointestinal Perforation |
3.4% |
| Respiratory Failure |
3.4% |
| Skin Test Positive |
3.4% |
| Speech Disorder Developmental |
3.4% |
| Urticaria |
3.4% |
| Wrong Drug Administered |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
17.8% |
| Anaesthesia |
10.6% |
| Rheumatoid Arthritis |
8.4% |
| Sedation |
8.1% |
| Hypertension |
7.2% |
| Pain |
5.9% |
| Drug Use For Unknown Indication |
5.7% |
| General Anaesthesia |
4.4% |
| Asthma |
4.2% |
| Muscle Relaxant Therapy |
4.2% |
| Duodenal Ulcer |
4.0% |
| Angina Pectoris |
3.2% |
| Muscle Spasms |
3.0% |
| Hypercholesterolaemia |
2.7% |
| Oral Surgery |
2.7% |
| Sensory Disturbance |
2.0% |
| Induction Of Anaesthesia |
1.7% |
| Hypotonia |
1.5% |
| Vomiting |
1.5% |
| Unevaluable Event |
1.2% |
|
| Renal Failure |
18.5% |
| Rhabdomyolysis |
13.0% |
| Torsade De Pointes |
11.1% |
| Convulsion |
9.3% |
| Tachycardia |
7.4% |
| Urticaria |
5.6% |
| Abdominal Pain Upper |
3.7% |
| Cardiac Arrest |
3.7% |
| Renal Tubular Necrosis |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Ulcer |
3.7% |
| Anaphylactic Reaction |
1.9% |
| Anaphylactoid Reaction |
1.9% |
| Ascites |
1.9% |
| Bronchospasm |
1.9% |
| Drug Effect Decreased |
1.9% |
| Extrasystoles |
1.9% |
| Hypotension |
1.9% |
| Incision Site Haemorrhage |
1.9% |
| Obstructive Airways Disorder |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.8% |
| Drug Use For Unknown Indication |
25.1% |
| Coronary Artery Bypass |
8.8% |
| Anaesthesia |
2.9% |
| Hypertension |
2.9% |
| Aortic Valve Replacement |
2.7% |
| Catheterisation Cardiac |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Pain |
1.6% |
| Tricuspid Valve Repair |
1.5% |
| Mitral Valve Replacement |
1.4% |
| Mitral Valve Repair |
1.3% |
| Anaesthetic Premedication |
1.1% |
| Cardiac Operation |
1.1% |
| Heart Transplant |
1.1% |
| Muscle Relaxant Therapy |
1.1% |
| Hypercholesterolaemia |
1.0% |
| Muscle Spasms |
1.0% |
| Asthma |
0.9% |
| Duodenal Ulcer |
0.9% |
|
| Pain |
12.0% |
| Anxiety |
11.4% |
| Renal Failure |
11.4% |
| Fear |
9.6% |
| Anhedonia |
7.2% |
| Unevaluable Event |
7.2% |
| Injury |
5.4% |
| Renal Impairment |
4.8% |
| Emotional Distress |
4.2% |
| Multi-organ Failure |
3.6% |
| Depression |
3.0% |
| Renal Failure Acute |
3.0% |
| Renal Injury |
2.4% |
| Respiratory Depression |
2.4% |
| Sepsis |
2.4% |
| Stress |
2.4% |
| Torsade De Pointes |
2.4% |
| Hypertension |
1.8% |
| Ventricular Fibrillation |
1.8% |
| Ventricular Tachycardia |
1.8% |
|
| Interacting |
| Product Used For Unknown Indication |
64.3% |
| General Anaesthesia |
28.6% |
| Antiemetic Supportive Care |
7.1% |
|
| Drug Interaction |
66.7% |
| Torsade De Pointes |
33.3% |
|
